Frozen shoulder, medically called adhesive capsulitis, peaks demographically right in the menopausal window; in one large series of over 2,000 patients the mean age was 56, and obesity and diabetes were significantly associated with it.
That demographic overlap with menopause is real, but no study has yet directly tested menopausal stage itself as a risk factor for frozen shoulder, so the hormonal link remains circumstantial rather than proven. Diabetes, by contrast, has a well-documented and much stronger link: people with diabetes have roughly five times the odds of developing frozen shoulder. The one direct pilot study of hormone therapy and frozen shoulder found a protective-looking trend, about 4% in hormone therapy users versus about 8% in non-users, but with only 152 treated women the result did not reach statistical significance, so it should be read as a hint worth following up, not proof.
The disagreement is whether frozen shoulder's overlap with the menopausal age window reflects a real hormonal cause that hormone therapy could prevent, or whether it is better explained by metabolic factors like diabetes, which has much stronger direct evidence, while menopause itself has never been directly tested as a risk factor.
What the research shows, and which source each finding rests on
In a 2,190-patient series, the mean age of frozen shoulder patients was 56.4; obesity and diabetes were significantly associated.
People with diabetes have roughly 5 times the odds of adhesive capsulitis (95% CI 3.2-7.7); prevalence of adhesive capsulitis in diabetes is about 13.4%; about 30% of people presenting with adhesive capsulitis have diabetes.
A stricter meta-analysis of longitudinal studies estimated diabetes as a risk factor for frozen shoulder onset at OR 3.69 (case-control) and cohort hazard ratios of 1.32 and 1.67.
In a retrospective pilot of 1,952 postmenopausal women aged 40-60 (152 on hormone therapy), adhesive capsulitis occurred in 3.95% of hormone therapy users versus 7.65% of non-users, a protective-looking direction that did NOT reach statistical significance (OR 1.99 for non-use, 95% CI 0.86-4.58, p=0.10).
Where the real disagreement is
Each position is shown with its own sources. A position listed here is not necessarily the accepted view.
Hormonal causation, hormone therapy protective
Vonda Wright, Corinne Menn, Felice Gersh, clinical practice
The demographic bullseye of women aged 40-60, the presence of estrogen receptors in joint capsule tissue, inflammation biology, and the protective direction seen in the small pilot study together support a hormonal driver, and clinicians report the association constantly in their own patients.
Metabolic and idiopathic, hormones unproven
Reinke et al.; the diabetes literature
The only direct test of hormone therapy was statistically non-significant and based on a tiny exposed group of 152 women, while diabetes carries a far better-documented risk (odds roughly 3.7 to 5 times higher), and no study has yet measured frozen shoulder incidence by menopausal stage directly.
What would settle it: The large prospective study the pilot authors themselves call for, directly testing menopausal stage as an exposure for frozen shoulder incidence, would settle this.
What is really going on here
- New frozen shoulder: should we check my HbA1c and glucose?
- The '99% protection from frozen shoulder' claim - what does the actual study show?
Questions for your doctor
- Should we check my blood sugar or HbA1c given a new frozen shoulder?
- Is hormone therapy an evidence-based option for preventing or treating frozen shoulder specifically, or is that unproven?
- What's the recommended physical therapy approach for frozen shoulder?
- How long does frozen shoulder typically take to resolve?
Questions with no answer yet
Would the large prospective study explicitly called for by the pilot study's own authors, directly testing menopausal stage as a risk factor for frozen shoulder, find a real hormonal link, or would it show the association is fully explained by diabetes, obesity, and age instead?
Not directly studied yetNo research does not mean it does not work, and it does not mean it works. It means nobody has tested it yet.
What is known: This exact large prospective study is described as what would settle the question, and it has not been done. The only direct test of hormone therapy so far found a protective-looking trend that did not reach statistical significance in a small exposed group of 152 women.
What would test it: The large prospective study described above, directly testing menopausal stage as an exposure for frozen shoulder incidence.
If a properly powered version of the small hormone therapy pilot study enrolled ten times as many treated women, would the protective trend, about 4 percent versus about 8 percent, become statistically significant, or would it shrink toward no difference at all?
Not directly studied yetNo research does not mean it does not work, and it does not mean it works. It means nobody has tested it yet.
What is known: The pilot study's own numbers point in a protective direction but did not reach significance with only 152 treated women, framed explicitly as a promising signal, not proof, since the study was designed to address research design issues rather than to be definitive.
What would test it: An adequately powered follow-up study, ideally randomized, with enough treated women to detect or rule out the effect size seen in the pilot.
Does the demographic overlap between frozen shoulder and menopause exist mainly because midlife women are more likely to have undiagnosed insulin resistance or prediabetes, meaning the real driver is metabolic rather than hormonal?
Not directly studied yetNo research does not mean it does not work, and it does not mean it works. It means nobody has tested it yet.
What is known: Diabetes carries a far better-documented and larger risk association with frozen shoulder, roughly 3.7 to 5 times higher odds, than anything shown for hormone status, and no study has directly tested whether metabolic status, rather than menopausal status, fully accounts for the female midlife peak in frozen shoulder rates.
What would test it: A study statistically modeling menopausal status alongside metabolic markers, such as glucose and insulin resistance, together, to see which one independently predicts frozen shoulder risk once the other is accounted for.
Sources
- 1.Shoulder adhesive capsulitis: epidemiology and predictors of surgery.Kingston K, et al. Shoulder adhesive capsulitis: epidemiology and predictors of surgery. J Shoulder Elbow Surg 2018;27(8):1437-1443 · Comparative or small study
- 2.Adhesive capsulitis of the shoulder and diabetes: a meta-analysis of prevalence.Zreik NH, Malik RA, Charalambous CP. Adhesive capsulitis of the shoulder and diabetes: a meta-analysis of prevalence. Muscles Ligaments Tendons J 2016;6(1):26-34 · Systematic review or guideline
- 3.Diabetes as a risk factor for the onset of frozen shoulder: a systematic review and meta-analysis.Dyer BP, et al. Diabetes as a risk factor for the onset of frozen shoulder: a systematic review and meta-analysis. BMJ Open 2023;13(1):e062377 · Systematic review or guideline
- 4.A preliminary pilot study to address design issues related to research on potential association of hormone therapy and adhesive capsulitis.Reinke EK, et al. A preliminary pilot study to address design issues related to research on potential association of hormone therapy and adhesive capsulitis. Climacteric 2026;29(3):478-483 · Observational study
The letter grades the type of study behind a claim, not the answer itself.
This page is general information based on published research and public sources. It is not medical advice and not a personal assessment, and it does not replace a conversation with your doctor. Peritale is a wellness product, not a medical device, and is not intended to diagnose, treat, cure or prevent any disease. For any medical question, speak with a licensed clinician.
You are not imagining it
In about seven minutes on your phone, Peritale reads five signal systems and maps your symptoms, so you can see that what you feel is real, follow your hormonal transition over time, and walk into your doctor ready to ask for the care you deserve. Your first check is free, no credit card.
Start Free MappingRelated questions
- Why do my joints suddenly ache in perimenopause?
- Is menopause really wrecking my skin, and is it true I lose 30% of my collagen in the first five years?
- Why is my hair thinning - is this actually caused by menopause?
- Why are my eyes suddenly so dry, and could my hormone therapy actually be making it worse?
- Is menopause really affecting my hearing, and does hormone therapy help or hurt it?
- I keep getting heart palpitations around perimenopause - is this hormonal, or something I need checked out?
- Back to topic: Whole-body symptoms